Literature DB >> 30263499

Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.

Jin-Wook Kang1,2, Min-Ji Kim1,2, Hyun-Ah Baek3, Jeong-Sang Lee1,2,3.   

Abstract

The microRNAs (miRNAs) negatively regulate the stability and translation of target messenger RNAs by selectively binding. It has been implicated in diverse processes such as cellular differentiation, cell-cycle control, apoptosis, and carcinogenesis. Examination of tumor-specific miRNA expression profiles has revealed wide spread dysregulation of these molecules in diverse cancers. The available genomic bulk evidences were extracted from The Cancer Genome Atlas by using IluminaGA_miRNASeq platform in human breast cancer samples. After mining collected data, group of each miRNA ID was analyzed through five D/Bs (mirWalk, miranda, mirDB, RNA22, and TargetScan) on predicted and validated miRNA targets. Oncogenes known to have a high correlation with breast cancer (C-myc, HER2, cyclin D-1, N-RAS, FGF-4, FGF-3, BRCA1, and BRCA2) are subject in this study to select their relevant miRNAs. Function of miRNA regulation will be essential to achieve a complete understanding of carcinogenesis and these miRNAs would be potential target for breast cancer prevention.

Entities:  

Keywords:  breast cancer; chemoprevention; data mining; microRNA; target

Year:  2016        PMID: 30263499      PMCID: PMC6049403          DOI: 10.1007/s10068-016-0111-x

Source DB:  PubMed          Journal:  Food Sci Biotechnol        ISSN: 1226-7708            Impact factor:   2.391


  40 in total

1.  Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA.

Authors:  Lin Zhang; Dongxia Hou; Xi Chen; Donghai Li; Lingyun Zhu; Yujing Zhang; Jing Li; Zhen Bian; Xiangying Liang; Xing Cai; Yuan Yin; Cheng Wang; Tianfu Zhang; Dihan Zhu; Dianmu Zhang; Jie Xu; Qun Chen; Yi Ba; Jing Liu; Qiang Wang; Jianqun Chen; Jin Wang; Meng Wang; Qipeng Zhang; Junfeng Zhang; Ke Zen; Chen-Yu Zhang
Journal:  Cell Res       Date:  2011-09-20       Impact factor: 25.617

Review 2.  The diverse functions of microRNAs in animal development and disease.

Authors:  Wigard P Kloosterman; Ronald H A Plasterk
Journal:  Dev Cell       Date:  2006-10       Impact factor: 12.270

Review 3.  Experimental validation of miRNA targets.

Authors:  Donald E Kuhn; Mickey M Martin; David S Feldman; Alvin V Terry; Gerard J Nuovo; Terry S Elton
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

4.  Interactive exploration of RNA22 microRNA target predictions.

Authors:  Phillipe Loher; Isidore Rigoutsos
Journal:  Bioinformatics       Date:  2012-10-16       Impact factor: 6.937

Review 5.  MicroRNAs-mediated cell fate in triple negative breast cancers.

Authors:  Xinbing Sui; Xian Wang; Weidong Han; Da Li; Yinghua Xu; Fang Lou; Jichun Zhou; Xidong Gu; Jing Zhu; Cheng Zhang; Hongming Pan
Journal:  Cancer Lett       Date:  2015-03-03       Impact factor: 8.679

6.  Genetic pathways linking hemostasis and cancer.

Authors:  Delphine Garnier; Nathalie Magnus; Esterina D'Asti; Maryam Hashemi; Brian Meehan; Chloe Milsom; Janusz Rak
Journal:  Thromb Res       Date:  2012-04       Impact factor: 3.944

7.  MicroRNA responses to cellular stress.

Authors:  Carmen J Marsit; Karen Eddy; Karl T Kelsey
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

8.  Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.

Authors:  Susanne Osanto; Yongjun Qin; Henk P Buermans; Johannes Berkers; Evelyne Lerut; Jelle J Goeman; Hendrik van Poppel
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

9.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

Review 10.  MiRNAs and Other Epigenetic Changes as Biomarkers in Triple Negative Breast Cancer.

Authors:  Andrea Mathe; Rodney J Scott; Kelly A Avery-Kiejda
Journal:  Int J Mol Sci       Date:  2015-11-30       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.